Singapore is worse today

Singapore is worse today. As you may know, Singapore is a fairly strict place regarding laws and enforcement. Singapore did lockdowns, distancing, masking and is 79% vaccinated.

It appears to be almost universal, government agencies and pharmaceutical companies have been wrong during this plandemic; experts like Geert Vanden Bossche, Luc Montagnier, Peter McCullough, Robert Malone, Martin Kulldorff, Jay Bhattacharya, Sunetra Gupta and thousands of other front line doctors and scientists were right when they told us to treat early, treat those at risk, and that immune escape and antibody-dependent enhancement would result from mass vaccinations, lockdowns, masking, etc., – mistakes during an epidemic – in addition to increasing damages from of adverse effects from each of these government and employer mandated responses. Thousands of doctors and scientists stood up, petitioned, zoomed, spoke up in towns and meetings, social media, and were banned, but governments and major employers are not listening. The U.S. FDA is a perfect example; it ignored the 18-3 vote against vax boosters by its own expert advisory council.

Governments have been taken captive. Altogether, the actions of government and major employers are worsening what was once an epidemic with about 99% survivability. Variants are evolving, pressured to become more infectious to evade the mandates. This is not new information. (Like the Taliban.) Yet, most governments are still not accepting advice to return to early treatment, doctor-patient relations, patient consent, for example treatment with a well-known (Nobel prize winning) FDA-approved, inexpensive, and effective drug, in spite of its successful record fighting SARS CoV2 virus and its enviable safety record.

Milton Friedman said, “If you put the federal government in charge of the Sahara Desert, in 5 years there’d be a shortage of sand.” There is an analogy there that applies to government healthcare, this epidemic and almost all governments.

About budbromley

Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.